Non-linear mixed effects models for the evaluation of dissolution profiles

被引:42
作者
Adams, E
Coomans, D
Smeyers-Verbeke, J
Massart, DL
机构
[1] Free Univ Brussels, Inst Pharm, B-1090 Brussels, Belgium
[2] James Cook Univ N Queensland, Sch Math & Phys Sci, Townsville, Qld 4811, Australia
关键词
dissolution; non-linear mixed effects models; pharmaceutical statistics; longitudinal data;
D O I
10.1016/S0378-5173(02)00127-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The use of non-linear mixed effects models to describe dissolution data has been evaluated, A theoretical part is included to introduce this approach to scientists who are not Familiar with this type of statistics. The standard settings of the statistical software package (S-plus) are used as much as possible. Several mathematical functions like the Weibull, logistic, first-order and Gompertz are employed as basis for the non-linear mixed effects models. Examples are given using dissolution data of immediate and extended release tablets, The results are compared with those obtained using linear mixed effects models. (C) 2002 Elsevier Science B,V. All rights reserved.
引用
收藏
页码:37 / 53
页数:17
相关论文
共 17 条
[1]   Application of linear mixed effects models to the evaluation of dissolution profiles [J].
Adams, E ;
Coomans, D ;
Smeyers-Verbeke, J ;
Massart, DL .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 226 (1-2) :107-125
[2]   Evaluation of dissolution profiles using principal component analysis [J].
Adams, E ;
De Maesschalck, R ;
De Spiegeleer, B ;
Vander Heyden, Y ;
Smeyers-Verbeke, J ;
Massart, DL .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (01) :41-53
[3]   An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles [J].
Anderson, NH ;
Bauer, M ;
Boussac, N ;
Khan-Malek, R ;
Munden, P ;
Sardaro, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (4-5) :811-822
[4]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[5]  
CROWDER MJ, 1996, APPL STAT-J ROY ST C, V45, P323, DOI DOI 10.2307/2986091
[6]  
*FDA GUID IND, 1995, IMM REL SOL OR DOS F
[7]  
*FDA GUID IND, 1997, DISS TEST IMM REL SO
[8]   LINEARIZATION OF DISSOLUTION RATE CURVES BY WEIBULL DISTRIBUTION [J].
LANGENBUCHER, F .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1972, 24 (12) :979-+
[9]  
Moore J.W., 1996, PHARM TECHNOL, V20, P64, DOI DOI 10.1017/CCOL521633230.011
[10]  
Pinheiro J., 2009, Mixed-Effects Models in S and S-PLUS, DOI DOI 10.1007/B98882